logo

Neurocrine Biosciences Inc (NBIX)



Trade NBIX now with
  Date
  Headline
1/8/2021 7:33:49 AM Neurocrine Biosciences Preliminary 2020 INGREZZA Net Product Sales And TRx Both Up 32% To About $993 Mln
11/10/2020 7:14:30 AM William Blair Is Cutting Neurocrine Biosciences Inc (NBIX) FY22 Rev. Estimate To 1.44 Billion From 1.87 Billion
11/10/2020 7:14:11 AM William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY21 Rev. Estimate To 1.16 Billion From 1.49 Billion
11/10/2020 7:13:58 AM William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY20 Rev. Estimate To 1.06 Billion From 1.15 Billion
11/10/2020 7:13:30 AM William Blair Is Cutting Neurocrine Biosciences Inc (NBIX) FY22 Estimate To 4.41 From 7.14
11/10/2020 7:13:03 AM William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY21 Estimate To 3.66 From 5.85
11/10/2020 7:12:45 AM William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY20 Estimate To 4.11 From 4.81
11/10/2020 7:11:59 AM William Blair Reiterates Neurocrine Biosciences Inc (NBIX) At Outperform
11/9/2020 4:03:48 PM Neurocrine Biosciences Q3 Loss/share $0.62 Vs. Profit $0.56 Year Ago
10/7/2020 6:51:24 AM Neurocrine Biosciences And Me2/Orchestra Team Up With Mental Health Advocacy Community To Launch Monumental Moments
9/28/2020 4:04:03 PM Neurocrine Biosciences To Present New Data Analyses Of ONGENTYS In Patients With Parkinson's Disease
9/14/2020 8:57:49 AM Neurocrine Reports Once-Daily ONGENTYS Available In US As Add-On Treatment For Patients With Parkinson's Disease
9/14/2020 6:52:48 AM William Blair Reiterates Neurocrine Biosciences Inc (NBIX) At Outperform
8/3/2020 4:04:44 PM Neurocrine Biosciences Q2 EPS $0.81 Vs. $0.54 Year Ago